MoneyMatters Blog

    
AlphaProfit MoneyMatters Investing Blog RSS Feed

"In the investing blog, I seek to help you take sound investment decisions free from emotion by sharing my objective insights on markets, sectors, and companies."
Sam Subramanian PhD, MBA, Editor, AlphaProfit MoneyMatters

Yacktman Fund YACKX – A Top US Mutual Fund?

Calls for U. S. investors to invest overseas get louder each day. While overseas investments can help investors diversify their mutual fund portfolios, domestic investments need not be overlooked. Selected domestic mutual funds have achieved stellar returns since the market bottomed in March. One such fund is the no-load Yacktman Fund (YACKX) managed by the father and son… Read More »

Biotech Stocks and ETFs: Should You Board the Biotech Bandwagon Now?

July has been a good month for biotech investors. Share prices in the biotech sector as measured by the NYSE Biotechnology Index are up 24% compared to the 6.6% gain for the S&P 500. Earlier in the month, Amgen (AMGN) reported better-than-expected results from a trial of its experimental bone-protecting drug denosumab in patients with advanced breast cancer.… Read More »

Sector Investing: Should You Be in the Tech Sector Now?

The week past was a noteworthy one for technology investors. Share prices in this sector zoomed higher by 9.4%. After Tuesday’s market close, Intel’s (INTC) second quarter earnings announcement injected life back into the stock market and triggered a bull stampede in many tech names. The Good Intel reported its strongest growth from the first quarter to the… Read More »

New ETF and Mutual Fund Recommendations


New Mutual Fund Recommendations

The AlphaProfit no-load, no-transaction fee growth model portfolio is up 400% since the start of 2009 compared to the 287% gain for its benchmark. The model portfolio will be reconstituted with new recommendations on Friday, May 20. Learn more about AlphaProfit's Free and Premium Service investment newsletters.